GlassScriptPhysician profile
Mihaela Michael
NPI 1912419169
$3,409.67
in general payments reported to CMS, 2019-2025
18 companies · $979 in 2025
The $979 reported for 2025 was more than what 85% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $484 · 2022: $390 · 2023: $634 · 2024: $922 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,535.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,424.38 | 2021-2025 | Farxiga, Lokelma, Wainua |
| Novartis Pharmaceuticals Corporation | $440.50 | 2023-2025 | |
| Novo Nordisk INC | $321.82 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $306.48 | 2022-2025 | Jardiance |
| Pfizer INC. | $251.65 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $151.17 | 2022-2023 | Xarelto |
| Amgen INC. | $125.99 | 2023-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $112.73 | 2022-2024 | Eliquis, Camzyos |
| Cvrx, INC. | $53.04 | 2024-2025 | Barostim Neo System |
| Scpharmaceuticals INC. | $48.37 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.93 | 2022-2023 | Lifevest |
| Silk Road Medical, INC. | $26.05 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Abbott Laboratories | $24.16 | 2025 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $19.06 | 2025 | Fluent Fluid Management System |
| Impulse Dynamics (USA) INC. | $18.51 | 2025 | Optimizer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16.79 | 2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $16.70 | 2022 | |
| Edwards Lifesciences Corporation | $14.34 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mihaela Michael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.